Cited by 924Drug-Induced Hepatotoxicity and ProtectionPharmacovigilance and Adverse Drug ReactionsDrug-Induced Adverse Reactions

The DOI matches its Crossref record; 982 of the 982 references it cites were found in a registry or an index.

Drug-induced liver injury

Open access

Andrade, Raul J., Chalasani, Naga, Björnsson, Einar S., Suzuki, Ayako, Kullak-Ublick, Gerd A., Watkins, Paul B., Devarbhavi, Harshad, Merz, Michael, Lucena, M. Isabel, Kaplowitz, Neil, Aithal, Guruprasad P.·2019·Nature Reviews Disease Primers

DOI 10.1038/s41572-019-0105-0

Open this paper in CoChat — free account Open PDF

Abstract

Drug-induced liver injury (DILI) is an adverse reaction to drugs or other xenobiotics that occurs either as a predictable event when an individual is exposed to toxic doses of some compounds or as an unpredictable event with many drugs in common use. Drugs can be harmful to the liver in susceptible individuals owing to genetic and environmental risk factors. These risk factors modify hepatic metabolism and excretion of the DILI-causative agent leading to cellular stress, cell death, activation of an adaptive immune response and a failure to adapt, with progression to overt liver injury. Idiosyncratic DILI is a relative rare hepatic disorder but can be severe and, in some cases, fatal, presenting with a variety of phenotypes, which mimic other hepatic diseases. The diagnosis of DILI relies on the exclusion of other aetiologies of liver disease as specific biomarkers are still lacking. Clinical scales such as CIOMS/RUCAM can support the diagnostic process but need refinement. A number of clinical variables, validated in prospective cohorts, can be used to predict a more severe DILI outcome. Although no pharmacological therapy has been adequately tested in randomized clinical trials, corticosteroids can be useful, particularly in the emergent form of DILI related to immune-checkpoint inhibitors in patients with cancer.

Integrity signals

Registry

Crossref · 10.1038/s41572-019-0105-0

Cites

982 of 982 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

2 of 2

2 retracted

WITHDRAWN: Reference intervals for putative biomarkers of drug-induced liver injury and liver regeneration in healthy human volunteers
Francis, B., Clarke, J. I., Walker, L. E., Brillant, N., Jorgensen, A., Park, B. K., Pirmohamed, M., & Antoine, D. J. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.04.024 · Cited by 4
Retracted
Retraction of Ahrens and Sastic, Successful Rechallenge with Voriconazole following Medication-Induced Hepatotoxicity
Ahrens, J. H., & Sastic, C. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04976-14 · Cited by 3
Retracted
Untitled work
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,673
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289
Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M. L., Reindollar, R., Goodman, Z. D., Koury, K. J., Ling, M.-H., & Albrecht, J. K. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06102-5 · Cited by 6,027

Show all 982 references

Research works printed but not linked: 3

Institute of Medicine. Exploring the Biological Contributions to Human Health: Does Sex Matter? (National Academies Press, 2001).
Sanjuan-Jimenez, R. et al. Prevalence of hepatitis E markers in Spanish patients with suspected drug-induced liver injury [abstract]. Hepatology 66, 423A (2017).
Abu-Sbeih, H., Styskel, B., Blechazz, B., Chalasani, N. & Miller, E. Clinically significant hepatotoxicity due to immune checkpoint inhibitors is rare but leads to treatment discontinuations in high proportion. Hepatology 68, 25A (2018).

Sorted by citations

Items 301–400 of 922

Insights gained into the injury mechanism of drug and herb induced liver injury in the hepatic microenvironment
Zhang, X., Geng, Q., Lin, L., Zhang, L., Shi, C., Liu, B., Yan, L., Cao, Z., Li, L., Li, L., et al. (2024) · Toxicology · doi:10.1016/j.tox.2024.153900 · Cited by 13
Oral administration of astilbin mitigates acetaminophen-induced acute liver injury in mice by modulating the gut microbiota
Yang, Q. Z., He, W.-H., Xie, L., Chen, T., Liu, R., Hu, J., Guo, J., Tan, G., Wu, F.-L., Gu, P., et al. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01383-9 · Cited by 13
The protective effect of two highly branched polysaccharides from corn silk fermented by Lactobacillus plantarum against acute liver injury
Wu, Y., Song, Y., Li, R., Han, Z., Li, L., & Yan, Y. (2024) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2024.122799 · Cited by 13
Lipid droplet-specific NIR fluorescent probe with large Stokes shift for assessing the effect of chronic drugs on drug-induced liver injury
Wang, D., Huang, W., Zhu, Y., Xie, Y., Pang, T., Feng, Z., Rizzello, L., Tian, X., & Zhang, Z. (2024) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2024.137089 · Cited by 13
Progress of cGAS-STING signaling pathway-based modulation of immune response by traditional Chinese medicine in clinical diseases
Zhi, H., Fu, H., Zhang, Y., Fan, N., Zhao, C., Li, Y., Sun, Y., & Li, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1510628 · Cited by 13
DNA Nanostructures for Rational Regulation of Cellular Organelles
Elblová, P., Anthi, J., Liu, M., Lunová, M., Jirsa, M., Stephanopoulos, N., & Lunov, O. (2025) · JACS Au · doi:10.1021/jacsau.5c00117 · Cited by 13
Near‐Infrared Biosensing of Drug‐Induced Cell‐Heterogeneous Injuries with an Ultrahigh Turn‐On Ratio
Hu, X., Yao, C. L., Wang, B., Zhang, Y., Yang, J., Dong, Y., Li, Y., Wang, D., Chen, X., Deng, Y., et al. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202503579 · Cited by 13
Functional metabolomics revealed functional metabolic-characteristics of chronic hepatitis that is significantly differentiated from acute hepatitis in mice
Wang, T., Hu, L., Lu, J., Xiao, M., Liu, J., Xia, H., & Lu, H. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106248 · Cited by 13
Synthesis and In vivo Evaluation of Hepatoprotective Effects of Novel Sulfur-Containing 1,4-Dihydropyridines and 1,2,3,4-Tetrahydropyridines
Dotsenko, V. V., Krivokolysko, B. S., Bibik, E. Y., Фролов, К. А., Aksenov, N. A., Aksenova, I. V., & Krivokolysko, S. G. (2022) · Current Bioactive Compounds · doi:10.2174/1573407219666221017095803 · Cited by 13
Scavenger receptor a is a major homeostatic regulator that restrains drug-induced liver injury
Guo, C., Liu, W., Liu, Z., Cai, J., Yu, X., Wang, H., Li, X., Zuo, D., Jiang, X., Zhang, B., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000044 · Cited by 13
Tricyclic antidepressants induce liver inflammation by targeting NLRP3 inflammasome activation
Mu, W., Xu, G., Wang, Z., Li, Q., Sun, S., Qin, Q., Li, Z., Shi, W., Dai, W., Zhan, X., et al. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01128-x · Cited by 13
Characterization of drug-induced liver injury associated with drug reaction with eosinophilia and systemic symptoms in two prospective DILI registries
Medina‐Cáliz, I., Sanabria‐Cabrera, J., Paz, M. V., Aukstikalne, L., Stephens, C. M., Robles‐Díaz, M., Pinazo-Bandera, J. M., García‐Cortés, M., Conde, I., Soriano, G., et al. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03630-0 · Cited by 13
Self-citation
Multi-Omics Integration to Reveal the Mechanism of Hepatotoxicity Induced by Dictamnine
Tu, C., Xu, Z., Tian, L., Yu, Z., Wang, T., Guo, Z., Zhang, J., & Wang, T. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.700120 · Cited by 13
Incretin-Based Drugs and the Risk of Acute Liver Injury Among Patients With Type 2 Diabetes
Pradhan, R., Yin, H., Yu, O. H. Y., & Azoulay, L. (2022) · Diabetes Care · doi:10.2337/dc22-0712 · Cited by 14
A novel NIR-II fluorescent probe for hydrogen peroxide detection in drug-induced liver injury
Chen, H., Zhou, H., Zhang, X., Ding, Y., Zhang, X., Xu, Q., Wang, B., Yin, C., & Fan, Q. (2024) · Chemical Communications · doi:10.1039/d4cc03512g · Cited by 12
Evaluating large language models' performance in answering common questions on drug-induced liver injury
Dong, Y., Zhang, Z., Zhi, Y., Li, X., Guo, T., He, L., Zhao, S., Yang, X., Tang, J. T., Zhong, W., et al. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101579 · Cited by 12
Epidemiology of Drug‐ and Herb‐Induced Liver Injury Assessed for Causality Using the Updated RUCAM in Two Hospitals from China
Chen, Y., Wang, C., Yang, H., Huang, P., Shi, J., Tong, Y., Jiang, J., Zhang, X., Chen, W., & Xuan, Z. (2021) · BioMed Research International · doi:10.1155/2021/8894498 · Cited by 12
Trovafloxacin drives inflammation-associated drug-induced adverse hepatic reaction by changing macrophage polarization
Yang, H., Park, T., Park, D., & Kang, M.-G. (2022) · Toxicology in Vitro · doi:10.1016/j.tiv.2022.105374 · Cited by 12
Intrahepatic infiltration of activated CD8+ T cells and mononuclear phagocyte is associated with idiosyncratic drug-induced liver injury
Yang, H., Han, J. W., Lee, J. J., Lee, A., Cho, S. W., Rho, P. R., Kang, M., Jang, J. W., Jung, E. S., Choi, J. Y., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1138112 · Cited by 12
Single-cell RNA sequencing to reveal non-parenchymal cell heterogeneity and immune network of acetaminophen-induced liver injury in mice
Li, X., Yang, Z., Lei, X., Lei, X., Ju, Y., Zheng, Y., Zheng, Y., Kong, X., Xue, F., Zhong, W., et al. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03513-4 · Cited by 12
Topical Diclofenac-Induced Hepatotoxicity
Delungahawatta, T., Pokharel, A., Paz, R., & Haas, C. J. (2023) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.55729/2000-9666.1190 · Cited by 12
Antibiotics modified by hydrophobic ion-pairing – A solution world's problems with resistant bacteria?
Kwiecień, K., Brzychczy‐Włoch, M., & Pamuła, E. (2023) · Sustainable materials and technologies · doi:10.1016/j.susmat.2023.e00662 · Cited by 12
Development and validation of risk prediction model for diabetic neuropathy among diabetes mellitus patients at selected referral hospitals, in Amhara regional state Northwest Ethiopia, 2005–2021
Gelaw, N. B., Muche, A. A., Alem, A. Z., Bekele, N., Chekol, Y. M., Tesfie, T. K., & Tebeje, T. M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0276472 · Cited by 12
H2O2-responsive dual-peak ratiometric NIR-II fluorescent probe for in situ hepatic oxidative stress level monitoring
Huang, Y. D., Huang, S., Liu, W., Tian, F., Grimes, C. A., Zhou, Y., & Cai, Q. (2023) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2023.134823 · Cited by 12
A sensitive upconverting nanoprobe based on signal amplification technology for real-time in situ monitoring of drug-induced liver injury
Meng, L., Zheng, X., Zheng, Z., Zhao, Z. Z., Wang, L., Zhou, P., Xin, G.-Z., Li, P., & Li, H. (2020) · Nanoscale · doi:10.1039/d0nr01493a · Cited by 12
Causality imputation between herbal products and HILI: An algorithm evaluation in a systematic review
Soares, P. F., Fernandes, M. T. C. F., Souza, A. D. S., Lopes, C. M., dos Santos, D. A. C., Oliveira, D. P. R., Pereira, M. G., Prado, N. M. D. B. L., Gomes, G. S. D. S., Santos, G., et al. (2021) · Annals of Hepatology · doi:10.1016/j.aohep.2021.100539 · Cited by 12
Drug-Associated Liver Injury Related to Antipsychotics
Zeiss, R., Häfner, S., Schönfeldt‐Lecuona, C., Connemann, B. J., & Gahr, M. (2022) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001576 · Cited by 12
Dual-targetable fluorescent probe for mapping the fluctuation of peroxynitrite in drug-induced liver injury model
Wang, Y., Liu, Y., Song, X., Feng, Y., Jing, C., Zhang, G., Huang, Y., & Liu, W. (2022) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2022.121892 · Cited by 12
Quantitative Systems Toxicology Modeling Informed Safe Dose Selection of Emvododstat in Acute Myeloid Leukemia Patients
Yang, K., Kong, R., Spiegel, R. J., Baird, J. D., O’Keefe, K., Howell, B. A., & Watkins, P. B. (2023) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.3136 · Cited by 11
Self-citation
Roadmap to DILI research in Europe. A proposal from COST action ProEuroDILINet
Lucena, M., Paz, M. V., Alvarez-Alvarez, I., Aithal, G. P., Björnsson, E. S., Cakan‐Akdogan, G., Cubero, F. J., Esteves, F., Falcón‐Pérez, J. M., Fromenty, B., et al. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.107046 · Cited by 11
Self-citation
The effects of alpha‐pinene against paracetamol‐induced liver damage in male rats
Rahimi, K., Rezaie, A., Allahverdi, Y., Shahriari, P., & Mirghaed, M. T. (2025) · Physiological Reports · doi:10.14814/phy2.70227 · Cited by 11
Enhancing the solubility and bioavailability of itraconazole through pharmaceutical cocrystallization: A promising strategy for drug formulation
Chhatbar, M., Borkhataria, C. H., Patel, O. P., Raichura, K., Pethani, T. M., Parmar, G. R., Mori, D., & Manek, R. A. (2025) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2025.103770 · Cited by 11
The SERCA–PLN–DWORF axis in cardiometabolic disease: mechanisms and therapeutic perspectives
Kim, O., Noh, S. W., Choi, J.-S., Jung, Y., & Oh, B. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-03023-w · Cited by 12
Investigating Mitochondrial Viscosity in Ferroptosis‐Mediated Drug‐Induced Liver Injury using a Double‐Targeted Strategy
Zhou, Y., Wang, Y., Huang, B., Lee, H., Yan, M., & Yoon, J. (2025) · Advanced Science · doi:10.1002/advs.202510425 · Cited by 11
A scalable human liver-on-a-chip platform for predictive safety assessment
Kulkarni, G., Chen, L., Sang, J., Seo, J. H., Grall, R., Wang, Y., Gilbride, P., Yuan, Y., Albaum-Getzen, M., McCormack, J., et al. (2025) · Toxicology · doi:10.1016/j.tox.2025.154378 · Cited by 11
A human liver organoids-on-chip for the assessment of drug-induced liver injury
Chen, X., 鲍方, Liu, J., Wang, Y., Tao, T., Zhang, G., & Qin, J. (2026) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-025-01074-z · Cited by 11
Hepatoprotective Effects of Phloridzin against Isoniazid-Rifampicin Induced Liver Injury by Regulating CYP450 and Nrf2/HO-1 Pathway in Mice
Jiao, Y., Li, G., Bao, X., Suo, Y., Xu, H., Deng, Y., Feng, T., & Deng, G. (2022) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c22-00466 · Cited by 11
Exploring the Hepatotoxicity of Drugs through Machine Learning and Network Toxicological Methods
Tang, T., Gan, X., Zhou, L., Pu, K., Wang, H., Dai, W., Zhou, B., Mo, L., & Zhang, Y. (2023) · Current Bioinformatics · doi:10.2174/1574893618666230316122534 · Cited by 11
Antifungal Drug-Drug Interactions with Commonly Used Pharmaceutics in European Pediatric Patients with Acute Lymphoblastic Leukemia
Sienkiewicz-Oleszkiewicz, B., Salamonowicz, M., Słonka, J., & Kałwak, K. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144637 · Cited by 11
Yin/Yang associated differential responses to Psoralea corylifolia Linn. In rat models: an integrated metabolomics and transcriptomics study
Zhang, M.-L., Zhao, X., Li, W., Wang, X., Niu, M., Zhang, H., Chen, Y., Kong, D.-X., Gao, Y. J., Guo, Y.-M., et al. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00793-x · Cited by 11
Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case–control study
Grove, J. I., Stephens, C. M., Lucena, M. I., Andrade, R. J., Weber, S., Gerbes, A. L., Bjornsson, E. S., Stirnimann, G., Daly, A. K., Hackl, M., et al. (2023) · Diagnostic and Prognostic Research · doi:10.1186/s41512-023-00155-z · Cited by 11
Self-citation
Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity
Yoon, J. G., Jang, D. G., Cho, S.-G., Lee, C., Noh, S. H., Seo, S. K., Yu, J. W., Chung, H. W., Han, K., Kwon, S. S., et al. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01172-8 · Cited by 11
Rechallenge in idiosyncratic drug-induced liver injury: An analysis of cases in two large prospective registries according to existing definitions
Pinazo-Bandera, J. M., Niu, H., Alvarez-Alvarez, I., Medina‐Cáliz, I., Campo‐Herrera, E. D., Ortega‐Alonso, A., Robles‐Díaz, M., Hernández, N. G. M., Paraná, R., Nunes, V., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107183 · Cited by 12
Self-citation
The Diagnostic Value of Liver Biopsy for Unexplained Liver Dysfunction: A Retrospective Study
Shi, R., Yang, F., Wu, H., & Liu, Y. (2024) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s460338 · Cited by 11
Spatial-temporal profiling of antibiotic metabolites using graphite dots-assisted laser desorption ionization mass spectrometry
Lv, R., Shi, R., Wu, E., Ma, C., Guo, R., Li, J., Ouyang, F., Fang, Q., Hu, L., Sun, C., et al. (2020) · Talanta · doi:10.1016/j.talanta.2020.121371 · Cited by 11
Differential iNKT and T Cells Activation in Non-Alcoholic Fatty Liver Disease and Drug-Induced Liver Injury
Caballano‐Infantes, E., García-García, A., Gomez, C. L., Cueto‐Sánchez, A., Robles‐Díaz, M., Ortega‐Alonso, A., Martín‐Reyes, F., Álvarez‐Álvarez, I., Arranz‐Salas, I., Ruiz‐Cabello, F., et al. (2021) · Biomedicines · doi:10.3390/biomedicines10010055 · Cited by 11
Self-citation
Bufotenines-loaded liposome exerts anti-inflammatory, analgesic effects and reduce gastrointestinal toxicity through altering lipid and bufotenines metabolism
Shen, L., Lv, X., Yang, X., Deng, S., Liu, L., Zhou, J., Zhu, Y., & Ma, H. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113492 · Cited by 11
Colonic oxygen microbubbles augment systemic oxygenation and CO2 removal in a porcine smoke inhalation model of severe hypoxia
Mountford, P. A., Leiphrakpam, P. D., Weber, H., McCain, A. R., Scribner, R. M., Scribner, R. T., Duarte, E. M., Chen, J., Noe, D., Borden, M. A., et al. (2023) · Intensive Care Medicine Experimental · doi:10.1186/s40635-023-00517-3 · Cited by 11
Hepatotoxicity of Antibiotics and Antifungals and Their Safe Use in Hepatic Impairment
Ma, J., Bjornsson, E. S., & Chalasani, N. (2024) · Seminars in Liver Disease · doi:10.1055/s-0044-1787062 · Cited by 10
Self-citation
Point-of-Care Testing of Whole Blood for Liver Injury Auxiliary Diagnosis with Biothiols Activable Chemiluminescent Probe
Zhu, J., Xu, S., Zhou, L., Zeng, Q., Wang, Y., Yan, M., & Liu, H. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c02831 · Cited by 10
Biological and clinical role of TREM2 in liver diseases
Ma, K., Guo, S., Li, J., Wei, T., & Liang, T. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000578 · Cited by 10
Deep Learning Prediction of Drug-Induced Liver Toxicity by Manifold Embedding of Quantum Information of Drug Molecules
Li, T., Li, J., Jiang, H., & Skiles, D. B. (2024) · Pharmaceutical Research · doi:10.1007/s11095-024-03800-4 · Cited by 10
GPR35 prevents drug-induced liver injury via the Gαs-cAMP-PKA axis in macrophages
Zhao, X., Li, Y., Yang, L., Chen, X., Zhang, J., Chen, T., Wang, H., Li, F., Chen, C., Wu, J., et al. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05751-4 · Cited by 10
Elucidating Molecular Mechanisms of Drug-Induced Hepatotoxicity of Lapatinib
Yu, Q., Ma, L., Norona, L. M., Dragovich, P. S., Wang, J., Wang, S., Chen, Y.-C., Khojasteh, S. C., Kenny, J. R., Dean, B. J., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01305 · Cited by 10
Paracetamol misusing to dental pain: a case-report and recommandations for treatment
Debortoli, C., Lan, R., Lafont, J., Campana, F., & Catherine, J. (2021) · Journal of Oral Medicine and Oral Surgery · doi:10.1051/mbcb/2021042 · Cited by 10
Enrichment Methods for Murine Liver Non-Parenchymal Cells Differentially Affect Their Immunophenotype and Responsiveness towards Stimulation
Medina‐Montano, C., Cacicedo, M. L., Svensson, M., Limeres, M. J., Zeyn, Y., Chaves-Giraldo, J. E., Röhrig, N., Grabbe, S., Gehring, S., & Bros, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126543 · Cited by 10
Peroxynitrite activatable double spiral ring derived fluorescent probe for imaging of inflammation and drug-induced liver injury
Shao, M., Li, L., Yu, F., Zhu, L., Jiang, M., & Yu, H. (2023) · Dyes and Pigments · doi:10.1016/j.dyepig.2023.111240 · Cited by 10
Liver injury in children: signal analysis of suspected drugs based on the food and drug administration adverse event reporting system
Liu, Y., Li, H., Huang, L., Wan, C., Wang, H., Jiao, X., Zeng, L., Jia, Z., Cheng, G., Zhang, L., et al. (2023) · BMC Pediatrics · doi:10.1186/s12887-023-04097-9 · Cited by 10
Deciphering the liver enigma: distinguishing drug-induced liver injury and metabolic dysfunction-associated steatotic liver disease—a comprehensive narrative review
García‐Cortés, M., Toro-Ortiz, J. P., & García-García, A. (2023) · Exploration of Digestive Diseases · doi:10.37349/edd.2023.00034 · Cited by 10
Comparison of drug-induced liver injury risk between propylthiouracil and methimazole: A quantitative systems toxicology approach
He, Q., Li, M., Ji, P., Zheng, A., Yao, L., Zhu, X., Shin, J., Lauschke, V. M., Han, B., & Xiang, X. (2024) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2024.117064 · Cited by 10
Physicochemical characterization and nanochemical analysis of ciprofloxacin hydrophobic ion Pairs for enhanced encapsulation in PLGA nanoparticle
Lee, J., Choi, M., Jeon, Y., Khanal, D., Lee, J., Kim, D., Chan, H., & Hwang, S. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125314 · Cited by 10
Drug-induced autoimmune-like hepatitis: A disproportionality analysis based on the FAERS database
Ye, W., Ding, Y., Li, M., Tian, Z., Wang, S., & Liu, Z. (2025) · PLoS ONE · doi:10.1371/journal.pone.0317680 · Cited by 10
The integration of metabolites from Forsythia suspensa and gut microbiota ameliorates drug-induced liver injury: network pharmacology and molecular docking studies
Wang, Y., Peng, X., Qian, B., Wang, L., & Wang, J. (2025) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2025.2475088 · Cited by 10
The double-edged role of hydrogen sulfide in the pathomechanism of multiple liver diseases
Liu, B., Wang, S., Xu, M., Ma, Y., Sun, R., Ding, H., & Li, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.899859 · Cited by 10
Machine Learning to Identify Interaction of Single-Nucleotide Polymorphisms as a Risk Factor for Chronic Drug-Induced Liver Injury
Moore, R., Ashby, K., Liao, T.-J., & Chen, M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182010603 · Cited by 10
The hepatoprotective potential of ferulic acid against a spectrum of pharmaceuticals and toxic compounds
Anandakumar, P., Chakraborty, B., Sen, N. B., & Kalappan, V. M. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-03996-3 · Cited by 10
Management of Apatinib-Related Adverse Events in Patients With Advanced Osteosarcoma From Four Prospective Trials: Chinese Sarcoma Study Group Experience
Xie, L., Xu, J., Guo, W., Wang, Z., Yao, Y., Li, J., Lin, J., Xiao, J., Yu, X., Zhang, W., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.696865 · Cited by 9
Establishment of an Idiosyncratic Drug-Induced Liver Injury Model on a Stacked Array Chip for Identification of CCL5-Mediated Paracrine Dynamics
Hou, Y., Gao, Z., Tu, P., Ai, X., & Jiang, Y. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c03552 · Cited by 9
A red fluorescent probe with new recognition site for tracking the fluctuation of biothiol in drug-induced liver injury model
Shi, S., Shen, R., Mi, L., Hao, J., Sayed, Z. N., Ma, Z., Sun, C., Wu, J., Zhang, H., & Zhang, B. (2025) · Analytica Chimica Acta · doi:10.1016/j.aca.2025.344364 · Cited by 9
Protective effects of melatonin and naringenin against acitretin induced hepatotoxicity via modulation of oxidative stress and inflammatory signaling
Sokar, S. S., Abu-Risha, S. E.-S., Alkabbani, M. A., Ramadan, L. A. A., & El‐Sisi, A. E. (2025) · Scientific Reports · doi:10.1038/s41598-025-16740-9 · Cited by 9
Genomic medicine in hepatology: mechanisms and liver treatment strategies
Kozlov, D., Rodimova, S. A., Filatov, P. V., Mozherov, A. M., Timashev, P. S., Zyuzin, M. V., & Kuznetsova, D. S. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01358-4 · Cited by 9
Critical role of OX40 in drug‐induced acute liver injury
Zhang, C., Jin, H., Wang, Y., Li, C., Zhao, X., Li, Y., Shi, W., Tian, Y., Xu, H., Tian, D., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15041 · Cited by 9
Incidence and Outcomes of Brucella Endocarditis in a High-Prevalence Area: A Single-Center Study
Pan, S., Zhao, Y., Zhou, K., Chen, S., Maimaitiming, M., Jing, W., Tuerxun, M., Chong, Y., & Zhu, J. (2024) · Journal of Epidemiology and Global Health · doi:10.1007/s44197-024-00232-6 · Cited by 9
The role and mechanism of SUMO modification in liver disease
Li, M., Zhang, J., Li, Z., Zhou, X., Qian, S., Tay, L. J., Zhang, Z., Yang, F., & Huang, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116898 · Cited by 9
Rosmarinic acid protects against cyclophosphamide-induced hepatotoxicity via inhibition of oxidative stress, inflammation, and apoptosis and upregulation of Nrf2 in mice
Alfwuaires, M. A. (2024) · Journal of Molecular Histology · doi:10.1007/s10735-024-10290-6 · Cited by 9
OTULIN orchestrates NCOA4-FTH1 complex to alleviate APAP-induced hepatocyte Ferroptosis
Gao, L., Chang, X., Han, Y., Li, J., Meng, Y., Yang, X., & Jiang, Z. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114490 · Cited by 9
The LAC Score Indicates Significant Fibrosis in Patients With Chronic Drug-Induced Liver Injury: A Large Biopsy-Based Study
Li, Z.-B., Chen, D., He, Q., Li, L., Zhou, G., Fu, Y., Deng, Y., Niu, X.-X., Chu, F., Gao, X.-P., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.734090 · Cited by 9
Inconsistencies and Ambiguities in Liver-Disease-Related Contraindications—A Systematic Analysis of SmPCs/PI of Major Drug Markets
Weisbach, L., Schuster, A. K., Hartmann, M., Fromm, M. F., Maas, R., & Farker, K. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11071933 · Cited by 9
Hepatobiliary Adverse Reactions during Treatment with Cladribine: Analysis of Data from the European Spontaneous Reporting System
Velișcu, E. M., Liguori, V., Anatriello, A., Maniscalco, G. T., Cantone, A., Costanzo, L. D., Stefanelli, P., Scavone, C., & Capuano, A. (2023) · Pharmaceuticals · doi:10.3390/ph16081071 · Cited by 9
Clinical Characteristics of 162 Patients with Drug‐Induced Liver and/or Kidney Injury
Wang, X., & Chen, X. (2020) · BioMed Research International · doi:10.1155/2020/3930921 · Cited by 9
Untargeted Metabolomics Reveals Anaerobic Glycolysis as a Novel Target of the Hepatotoxic Antidepressant Nefazodone
Krajnc, E., Visentin, M., Gai, Z., Stieger, B., Samodelov, S. L., Häusler, S., & Kullak-Ublick, G. A. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000120 · Cited by 9
Self-citation
Carboxypeptidase N1 is anticipated to be a synergy metrics for chemotherapy effectiveness and prognostic significance in invasive breast cancer
Cui, R., Wang, C., Li, T., Hua, J., Zhao, T., Ren, L., Wang, Y., & Li, Y. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02256-5 · Cited by 9
miR122-controlled all-in-one nanoplatform for in situ theranostic of drug-induced liver injury by visualization imaging guided on-demand drug release
Meng, L., Wang, Q., Wang, L., Zhao, Z. Z., Xin, G.-Z., Zheng, Z., Zhou, P., Li, P., Jiang, Y., & Li, H. (2021) · Materials Today Bio · doi:10.1016/j.mtbio.2021.100157 · Cited by 9
Automatic text classification of drug-induced liver injury using document-term matrix and XGBoost
Chen, M., Wu, Y., Wingerd, B., Liu, Z., Xu, J., Thakkar, S., Pedersen, T. J., Donnelly, T., Mann, N., Tong, W., et al. (2024) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2024.1401810 · Cited by 8
The Ways to Die: Cell Death in Liver Pathophysiology
Cao, P., Jaeschke, H., Ni, H., & Ding, W. (2025) · Seminars in Liver Disease · doi:10.1055/a-2576-4332 · Cited by 11
Glutamate dehydrogenase combined with ferrochelatase as a biomarker of liver injury induced by antituberculosis drugs
He, B., Cheng, X., Xiang, H., Li, Y., Zhang, Q., Wen-xing, P., & Yang, B. (2023) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15807 · Cited by 8
Amentoflavone mediated hepatoprotection to counteract paraquat instigated hepatotoxicity via modulating Nrf2/keap1 pathway: A biochemical, inflammatory, apoptotic and histopathological study
Ijaz, M. U., Ghafoor, N., Hayat, M. F., Almutairi, B. O., & Atique, U. (2023) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2023.105715 · Cited by 8
Inflammatory Bowel Disease Therapies and Acute Liver Injury
Catanzaro, R., Marotta, F., Yazdani, A., & Sciuto, M. (2024) · Toxics · doi:10.3390/toxics12060421 · Cited by 8
Label-Free Screening of Drug-Induced Liver Injury Using Stimulated Raman Scattering Microscopy and Spectral Phasor Analysis
Tipping, W. J., Wilson, L. T., Tomkinson, N. C. O., Faulds, K., & Graham, D. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c01285 · Cited by 8
Hepatotoxicity of antipsychotics: an exploratory pharmacoepidemiologic and pharmacodynamic study integrating FAERS data and in vitro receptor-binding affinities
Zeiss, R., Schönfeldt‐Lecuona, C., Connemann, B. J., Häfner, S., & Gahr, M. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1479625 · Cited by 8
Bacteroides fragilis 839 ameliorates anti-tuberculosis drugs-induced liver injury by suppressing inflammation and regulating gut microbiota in mice
Li, Q., Wu, C., Zhang, K., Zhou, Z., Li, J., Bai, J., Cao, J., & Shi, X. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1538528 · Cited by 8
An iron-deficient diet prevents alcohol- or diethylnitrosamine-induced acute hepatotoxicity in mice by inhibiting ferroptosis
Gao, Z., Wang, D., Zhang, H., Yang, J., Li, M., Lu, H., Shen, H., & Tang, Y. (2022) · Current Research in Food Science · doi:10.1016/j.crfs.2022.11.001 · Cited by 8
Hypothesis-driven modeling of the human lung–ventilator system: A characterization tool for Acute Respiratory Distress Syndrome research
Stroh, J. N., Smith, B. J., Sottile, P. D., Hripcsak, G. M., & Albers, D. J. (2022) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2022.104275 · Cited by 8
Scutellarein regulates the PTEN/AKT/NFκB signaling pathway to reduce pirarubicin related liver inflammation
Lan, Y., Chen, L., Zhu, J., Li, H., & Lin, Z. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5258 · Cited by 8
Self-Assembled Poly(rosmarinic acid) Nanoantioxidant for Enhanced Acute Liver Injury Treatment
Tang, P., Wu, H., Wang, M., Zhang, R., Liang, B., Li, X., & Xiao, W. (2023) · ACS Applied Nano Materials · doi:10.1021/acsanm.3c02555 · Cited by 8
Unique metabolomics characteristics for distinguishing cirrhosis related to different liver diseases: A systematic review and meta-analysis
Yang, L., Wang, F., Liu, S., Xian, Z., Yang, S., Xu, Y., Shu, L., Yan, X., He, J., Li, X., et al. (2024) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2024.103068 · Cited by 8
Causality assessment of skyfruit-induced liver injury using the updated RUCAM: a case report and review of the literature
Xia, C., Liu, Y., Yao, H., Zhu, W., Ding, J., & Jin, J. (2020) · Journal of International Medical Research · doi:10.1177/0300060520917569 · Cited by 8
Hepatic Macrophage activation and the LPS pathway in patients with different degrees of severity and histopathological patterns of drug induced liver injury.
Du, H., Zhao, S., Zhao, W. T., Fu, N., Li, W., Qin, X.-J., Zhang, Y., Nan, Y., & Zhao, J. (2021) · PubMed · doi:10.14670/hh-18-340 · Cited by 8
Hepatocyte‐Targeted Lipid Nanoparticle Delivery of HERC2 Plasmid Controls Drug‐Induced Hepatotoxicity by Limiting β‐Catenin‐Regulated CYP2E1 Expression
Liu, Y., Xu, Q., Liu, Y., Cao, S., Luo, J., Zheng, Z., Zhou, J., Lu, X., Zhang, L., Tan, Y., et al. (2024) · Advanced Science · doi:10.1002/advs.202401633 · Cited by 7
Mechanism and marker of voriconazole–induced liver injury: insights from a quantitative systems toxicology approach
Du, Q., Qiu, Y., Yang, L., Wang, C., Teng, M., Chen, J., Luo, Y., Sun, J., Wang, T., Chen, S., et al. (2025) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2025.105871 · Cited by 7

Authors: Andrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., & Aithal, G. P.
Affiliations: Indiana University School of Medicine (US)
Duke University (US)
Novartis (Switzerland) (CH)
University of North Carolina at Chapel Hill (US)
St.John's Medical College Hospital (IN)
University of Zurich (CH)
Spanish Clinical Research Network (ES)
Nottingham University Hospitals NHS Trust (GB)
Corresponding author: Lucena, M. Isabel
ORCID: Chalasani, Naga
Suzuki, Ayako
Kullak-Ublick, Gerd A.
Watkins, Paul B.
Devarbhavi, Harshad
Merz, Michael
Lucena, M. Isabel
Kaplowitz, Neil
Aithal, Guruprasad P.
Venue: Nature Reviews Disease Primers
Publisher: Springer Science and Business Media LLC
Published: 2019-08-22
Volume: 5
Issue: 1
Pages: 58-58
ISSN: 2056-676X (ISSN-L)
DOI: 10.1038/s41572-019-0105-0
OpenAlex: W1565605888
Cited by: 924
References: 982
Citations by year: 2026: 152 · 2025: 197 · 2024: 161 · 2023: 127 · 2022: 145 · 2021: 97 · 2020: 38
FWCI: 9.11
Type: journal article
Language: en
Open access: green
www.zora.uzh.ch
Licence: other-oa
www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Reviews Disease Primers (publishedVersion)
PubMed (publishedVersion)
Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
RISalud Institutional Health Repository of Andalucía (submittedVersion, cc-by-nc-nd)
Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
Zurich Open Repository and Archive (University of Zurich)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
Keywords: drug-induced liver injury, idiosyncratic drug reactions, xenobiotic toxicity, genetic susceptibility, hepatic metabolism, immune response, corticosteroids, immune checkpoint inhibitors, hepatotoxicity
MeSH terms: Biopsy, Humans, Risk Factors, Biomarkers, Chemical and Drug Induced Liver Injury

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Drug-induced liver injury

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Cited works that were retracted

Citations

Cites

Cited by

Related

Metadata

Record

About these checks